Literature DB >> 2731603

The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles: a study on a dry powder inhaler (Turbuhaler).

G Persson1, J E Wirén.   

Abstract

This study was carried out to investigate if particles approximately less than 5 microns are optimal when delivered from a dry powder inhaler. It was performed as a cumulative dose response study of twelve asthmatic adults. Three different versions of a dry powder inhaler, Bricanyl Turbuhaler, were studied. Each inhaler delivered 0.5 mg of pure terbutaline sulphate with each dose. Out of this 0.5 mg, they delivered 90 micrograms, 40 micrograms and 5 micrograms, respectively, of particles approximately less than 5 microns with each dose at an inspiratory flow rate of 28 l.min-1. Terbutaline 0.5 mg, 0.5 mg, 1.0 mg and 2.0 mg was inhaled with a 30 min interval between the doses. Forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) were measured 5 and 20 min after each dose. The bronchodilator response was greater with the inhaler delivering 90 micrograms of small particles with each dose than with the inhaler delivering 5 micrograms, thus confirming the importance of small (approximately less than 5 microns) particles.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731603

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

Review 1.  In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.

Authors:  Jolyon Mitchell; Steve Newman; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2007-12-21       Impact factor: 3.246

Review 2.  Inhalation delivery of asthma drugs.

Authors:  H Matthys
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Drug delivery from inhaler devices.

Authors:  H Bisgaard
Journal:  BMJ       Date:  1996-10-12

4.  Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters.

Authors:  T B Martonen; I M Katz
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

Review 5.  Antiasthma drug delivery. What is on the horizon?

Authors:  J C Virchow; C Kroegel; H Matthys
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

6.  In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.

Authors:  Arun Nair; Daniel Menzies; Pippa Hopkinson; Lesley McFarlane; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2009-02-09       Impact factor: 4.335

7.  Home assessment of peak inspiratory flow through the Turbohaler in asthmatic patients.

Authors:  R J Meijer; T W van der Mark; B J Aalders; D S Postma; G H Koëter
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.